Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 5.41 % |
3 Month Return | -11.16 % |
1 Year Return | -48.28 % |
Market Stats | |
Previous Close | ₹3.90 |
Open | ₹4.00 |
Volume | 10.79L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹15.60Cr |
P/E Ratio | 195 |
PEG Ratio | -7800 |
Market Cap | ₹15.60 Cr |
P/B Ratio | 5.75 |
EPS | 0.14 |
Dividend Yield | 0 |
Sector | Trading |
ROE | 7.02 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹15.60 Cr | 34.93% | 0.70 | -₹1 Cr | ₹27 Cr | |
NA | ₹454.34 Cr | 277.83% | 0.71 | NA | NA | |
NA | ₹112.37 Cr | 52.95% | 0.53 | ₹12 Cr | ₹487 Cr | |
NA | ₹21.57 Cr | -16.1% | 0.66 | NA | NA | |
NA | ₹21.85 Cr | 465.39% | 0.51 | NA | NA |
Organisation | Vivanza Biosciences Ltd |
Headquarters | |
Industry | Trading |
E-voting on shares | Click here to vote |
Key events for Vivanza Biosciences Ltd
Vivanza Biosciences reported a 46.32% YoY decrease in topline, with revenue declining by 32.6% QoQ. The loss increased by 309.27% YoY and 305.83% QoQ. Operating income decreased by 3344.44% YoY and 153.39% QoQ. EPS for Q4 was ₹-0.1, down by 285.65% YoY.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 59.95% to 60.13% in Sep 2024 quarter
Revenue Rich
Revenue is up for the last 2 quarters, 2.44 Cr → 3.0 Cr (in ₹), with an average increase of 18.7% per quarter
Promoter Holding Down
Promoters have decreased holdings from 40.05% to 39.86% in Sep 2024 quarter
Profit Down
Netprofit is down for the last 2 quarters, 0.27 Cr → 0.02 Cr (in ₹), with an average decrease of 92.6% per quarter
Price Dip
In the last 7 days, Vivanza Biosci. stock has moved down by -6.5%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 39.86% | ||
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 60.13% | 0.30 | |
Others | 0% | 0.00 |
Vivanza Biosciences Ltd in the last 5 years
Lowest (-15423.93x)
December 21, 2022
Industry (94.30x)
November 19, 2024
Today (195.00x)
November 19, 2024
Highest (884.71x)
July 19, 2023
Vivanza Biosciences Ltd’s net profit fell -92.31% since last year same period to ₹0.02Cr in the Q2 2024-2025. On a quarterly growth basis, Vivanza Biosciences Ltd has generated -92.59% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Vivanza Biosciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
Vivanza Biosciences Ltd (530057) share price today is ₹4
Vivanza Biosciences Ltd is not listed on NSE
Vivanza Biosciences Ltd is listed on BSE
PE Ratio of Vivanza Biosciences Ltd is 195
PE ratio = Vivanza Biosciences Ltd Market price per share / Vivanza Biosciences Ltd Earnings per share
Today’s traded volume of Vivanza Biosciences Ltd(530057) is 10.79L.
Today’s market capitalisation of Vivanza Biosciences Ltd(530057) is ₹15.6Cr.
Vivanza Biosciences Ltd(530057 | Price |
---|---|
52 Week High | ₹11.72 |
52 Week Low | ₹3.36 |
Vivanza Biosciences Ltd(530057) share price is ₹4. It is down -65.87% from its 52 Week High price of ₹11.72
Vivanza Biosciences Ltd(530057) share price is ₹4. It is up 19.05% from its 52 Week Low price of ₹3.36
Vivanza Biosciences Ltd(530057 | Returns |
---|---|
1 Day Returns | 0.1% |
1 Month Returns | 5.41% |
3 Month Returns | -11.16% |
1 Year Returns | -48.28% |